131 related articles for article (PubMed ID: 37254045)
1. Risk stratification for predicting postoperative recurrence of gastric cancer by grade of venous invasion.
Imai Y; Kurata Y; Ichinose M
BMC Gastroenterol; 2023 May; 23(1):189. PubMed ID: 37254045
[TBL] [Abstract][Full Text] [Related]
2. Risk stratification for predicting postoperative recurrence/metastasis of colorectal cancer by grade of venous invasion coupled with histological subtype.
Imai Y; Ichinose M
BMC Gastroenterol; 2022 Feb; 22(1):79. PubMed ID: 35197005
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Venous Invasion on the Postoperative Recurrence of pT1-3N0cM0 Gastric Cancer.
Imai Y; Kurata Y; Ichinose M
J Pers Med; 2023 Apr; 13(5):. PubMed ID: 37240905
[TBL] [Abstract][Full Text] [Related]
4. Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
Nishibeppu K; Komatsu S; Ichikawa D; Imamura T; Kosuga T; Okamoto K; Konishi H; Shiozaki A; Fujiwara H; Otsuji E
BMC Cancer; 2018 Jan; 18(1):108. PubMed ID: 29382310
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of venous invasion in stage IB node-negative gastric cancer.
Araki I; Hosoda K; Yamashita K; Katada N; Sakuramoto S; Moriya H; Mieno H; Ema A; Kikuchi S; Mikami T; Watanabe M
Gastric Cancer; 2015 Apr; 18(2):297-305. PubMed ID: 24687437
[TBL] [Abstract][Full Text] [Related]
6. Vascular invasion as an independent predictor of poor prognosis in nonmetastatic gastric cancer after curative resection.
Li P; Ling YH; Zhu CM; Hu WM; Zhang XK; Luo RZ; He JH; Yun JP; Li YF; Cai MY
Int J Clin Exp Pathol; 2015; 8(4):3910-8. PubMed ID: 26097575
[TBL] [Abstract][Full Text] [Related]
7. Different risk factors for three major recurrence patterns of pathological stage II or III gastric cancer patients who completed adjuvant S-1 monotherapy.
Kano Y; Ohashi M; Muneoka Y; Takahari D; Chin K; Yamaguchi K; Ida S; Kumagai K; Makuuchi R; Sano T; Nunobe S
Eur J Surg Oncol; 2021 Dec; 47(12):3097-3104. PubMed ID: 33931261
[TBL] [Abstract][Full Text] [Related]
8. Does three-dimensional surgery affect recurrence patterns in patients with gastric cancer after laparoscopic R0 gastrectomy? Results from a 3-year follow-up phase III trial.
Lu J; Xu BB; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Zheng CH; Huang CM; Li P
Surg Endosc; 2021 Jan; 35(1):113-123. PubMed ID: 31953725
[TBL] [Abstract][Full Text] [Related]
9. Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
Takahashi R; Ohashi M; Kano Y; Ida S; Kumagai K; Nunobe S; Chin K; Yamaguchi K; Nagino M; Sano T; Hiki N
Gastric Cancer; 2019 Nov; 22(6):1256-1262. PubMed ID: 30877407
[TBL] [Abstract][Full Text] [Related]
10. Favorable long-term outcomes of one-year adjuvant S-1 monotherapy for pathological stage II or III gastric cancer treated at a high-volume center.
Kano Y; Ohashi M; Hiki N; Takahari D; Chin K; Yamaguchi K; Tsuda Y; Shoji Y; Yasufuku I; Eto K; Ida S; Kumagai K; Nunobe S; Sano T
Gastric Cancer; 2018 Nov; 21(6):1024-1030. PubMed ID: 29700635
[TBL] [Abstract][Full Text] [Related]
11. Impact of Postoperative Complications on Recurrence in Patients With Stage II/III Gastric Cancer Who Received Adjuvant Chemotherapy With S-1.
Watanabe H; Hayashi T; Komori K; Hara K; Maezawa Y; Kano K; Shimoda Y; Fujikawa H; Aoyama T; Yamada T; Yamamoto N; Cho H; Ito H; Shiozawa M; Yukawa N; Morinaga S; Yoshikawa T; Rino Y; Masuda M; Ogata T; Oshima T
Anticancer Res; 2020 Mar; 40(3):1683-1690. PubMed ID: 32132075
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a prognostic nomogram for predicting early recurrence after curative resection of stage II/III gastric cancer.
Ma M; Xiao H; Li L; Yin X; Zhou H; Quan H; Ouyang Y; Huang G; Li X; Xiao H
World J Surg Oncol; 2019 Dec; 17(1):223. PubMed ID: 31856828
[TBL] [Abstract][Full Text] [Related]
13. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis.
Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068
[TBL] [Abstract][Full Text] [Related]
14. Robust vascular invasion concurrent with intense EGFR immunostaining can predict recurrence in patients with stage IB node-negative gastric cancer.
Araki I; Washio M; Yamashita K; Hosoda K; Ema A; Mieno H; Moriya H; Katada N; Kikuchi S; Watanabe M
Surg Today; 2018 May; 48(5):478-485. PubMed ID: 29256147
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A
Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578
[TBL] [Abstract][Full Text] [Related]
16. Clinical Impact of the Prognostic Nutritional Index as a Predictor of Outcomes in Patients with Stage II/III Gastric Cancer: A Retrospective Cohort Study.
Okubo K; Arigami T; Matsushita D; Tanaka T; Tsuruda Y; Noda M; Sasaki K; Mori S; Kurahara H; Ohtsuka T
Oncology; 2021; 99(6):380-388. PubMed ID: 33677434
[TBL] [Abstract][Full Text] [Related]
17. Tumor Infiltrative Pattern Predicts Sites of Recurrence After Curative Gastrectomy for Stages 2 and 3 Gastric Cancer.
Kanda M; Mizuno A; Fujii T; Shimoyama Y; Yamada S; Tanaka C; Kobayashi D; Koike M; Iwata N; Niwa Y; Hayashi M; Takami H; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Ann Surg Oncol; 2016 Jun; 23(6):1934-40. PubMed ID: 26847679
[TBL] [Abstract][Full Text] [Related]
18. Perioperative CRP: A novel inflammation-based classification in gastric cancer for recurrence and chemotherapy benefit.
Lu J; Xu BB; Xue Z; Xie JW; Zheng CH; Huang CM; Li P
Cancer Med; 2021 Jan; 10(1):34-44. PubMed ID: 33270989
[TBL] [Abstract][Full Text] [Related]
19. Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer.
Jiang N; Deng JY; Ding XW; Ke B; Liu N; Liang H
J Surg Res; 2014 Nov; 192(1):90-7. PubMed ID: 24953988
[TBL] [Abstract][Full Text] [Related]
20. Association Between Lymph Node Ratio and Survival in Patients with Pathological Stage II/III Gastric Cancer.
Kano K; Yamada T; Yamamoto K; Komori K; Watanabe H; Hara K; Shimoda Y; Maezawa Y; Fujikawa H; Aoyama T; Tamagawa H; Yamamoto N; Cho H; Shiozawa M; Yukawa N; Yoshikawa T; Morinaga S; Rino Y; Masuda M; Ogata T; Oshima T
Ann Surg Oncol; 2020 Oct; 27(11):4235-4247. PubMed ID: 32424582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]